-
Loading metrics
The Anti-Melanoma Activity of Dinaciclib, a Cyclin-Dependent Kinase Inhibitor, Is Dependent on p53 Signaling
- Brijal M. Desai,
- Jessie Villanueva,
- Thierry-Thien K. Nguyen,
- Mercedes Lioni,
- Min Xiao,
- Jun Kong,
- Clemens Krepler,
- Adina Vultur,
- Keith T. Flaherty,
- Katherine L. Nathanson
x
- Published: March 18, 2013
- https://doi.org/10.1371/journal.pone.0059588